These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21345133)

  • 21. New skin cancer target could delay drug resistance.
    Oncology (Williston Park); 2013 Mar; 27(3):164. PubMed ID: 23687783
    [No Abstract]   [Full Text] [Related]  

  • 22. Attacking cancer with molecularly targeted agents.
    Santoro M; Carlomagno F
    Curr Opin Pharmacol; 2013 Aug; 13(4):483-5. PubMed ID: 23871444
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics, clinical indications, and resistance mechanisms in molecular targeted therapies in cancer.
    Izar B; Rotow J; Gainor J; Clark J; Chabner B
    Pharmacol Rev; 2013; 65(4):1351-95. PubMed ID: 24092887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New research shows why advanced cancers recur after targeted treatments.
    Printz C
    Cancer; 2012 Oct; 118(20):4913. PubMed ID: 23042616
    [No Abstract]   [Full Text] [Related]  

  • 25. The roadmap of TRAIL apoptotic pathway-targeted cancer therapies: What is next?
    Bellail AC; Hao C
    Expert Rev Anticancer Ther; 2012 May; 12(5):547-9. PubMed ID: 22594889
    [No Abstract]   [Full Text] [Related]  

  • 26. Integrated patient and tumor genetic testing for individualized cancer therapy.
    Hertz DL; McLeod HL
    Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology.
    Petty RD
    Clin Oncol (R Coll Radiol); 1996; 8(3):186-9. PubMed ID: 8814375
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fewer targets and more processes or a poliorcetic digress from the use of the medical oncologist].
    Evrard S
    Bull Cancer; 2016; 103(7-8):607-9. PubMed ID: 27422490
    [No Abstract]   [Full Text] [Related]  

  • 29. Calculated resistance in cancer.
    Sawyers CL
    Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
    [No Abstract]   [Full Text] [Related]  

  • 30. [Genome analysis and cancer therapy].
    Tahara H
    Nihon Geka Gakkai Zasshi; 2005 Nov; 106(11):706-9. PubMed ID: 16304819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Exploitation of expression profiles: examples in oncology].
    Galiègue S; Casellas P
    J Soc Biol; 2002; 196(4):313-5. PubMed ID: 12645302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
    Arnedos M; Vielh P; Soria JC; Andre F
    J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug research in oncology; advances in the genome era].
    Bins S; Schellens JH; Voest EE; Sleijfer S
    Ned Tijdschr Geneeskd; 2014; 158():A6801. PubMed ID: 24618235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is tailored therapy feasible in oncology?
    Gasparini G; Longo R; Torino F; Gattuso D; Morabito A; Toffoli G
    Crit Rev Oncol Hematol; 2006 Jan; 57(1):79-101. PubMed ID: 16337806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted therapy for human epidermal growth factor receptor 2-positive breast cancer: can there be too many active drugs?
    Chandarlapaty S; Modi S
    J Clin Oncol; 2011 Aug; 29(23):3111-3. PubMed ID: 21730267
    [No Abstract]   [Full Text] [Related]  

  • 36. Mathematical modelling: Forecasting cancer.
    Gammon K
    Nature; 2012 Nov; 491(7425):S66-7. PubMed ID: 23320294
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular crosstalk between the proteasome, aggresomes and autophagy: translational potential and clinical implications.
    Driscoll JJ; Chowdhury RD
    Cancer Lett; 2012 Dec; 325(2):147-54. PubMed ID: 22781397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
    Scholler N
    IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular analysis for therapy choice: NCI MATCH.
    Conley BA; Doroshow JH
    Semin Oncol; 2014 Jun; 41(3):297-9. PubMed ID: 25023344
    [No Abstract]   [Full Text] [Related]  

  • 40. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.
    Rossig C; Juergens H; Berdel WE
    Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.